Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors

MeSH terms

• Antineoplastic Agents / adverse effects*
• Carboplatin / adverse effects
• Clinical Trials as Topic
• Combined Modality Therapy
• Drug Evaluation
• Etoposide / adverse effects
• Granulocyte Colony-Stimulating Factor / adverse effects
• Granulocyte Colony-Stimulating Factor / pharmacokinetics
• Granulocyte Colony-Stimulating Factor / therapeutic use*
• Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects
• Granulocyte-Macrophage Colony-Stimulating Factor / pharmacokinetics
• Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
• Humans
• Injections, Subcutaneous
• Neutropenia / chemically induced
• Neutropenia / drug therapy*